Funder: National Institutes of Health
Due Dates (Anticipated): June 2026 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $5,200,000; ~8 awards expected; individual award size not specified.
Summary: Supports a consortium to systematically identify, rigorously evaluate, validate, and harmonize biomarkers critical for the prevention, diagnosis, and clinical management of Type 1 Diabetes.
Key Information: This is a forecasted opportunity; all deadlines are projected and may change.